Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;32(4):199-203.
doi: 10.1002/clc.20317.

Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients

Offer Amir  1 , Hagar Paz, Ori Rogowski, Marina Barshai, Moran Sagiv, Sergei Shnizer, Abraham Z Reznick, Ruthie E Amir
Affiliations

Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients

Offer Amir et al. Clin Cardiol. 2009 Apr.

Abstract

Background: Serum oxidative stress (OS) level has an important role in the inflammatory process of heart failure.

Hypothesis: The study was designed to analyze serum OS levels in chronic heart failure (HF) patients and to examine the relation between OS levels and other clinical and prognostic parameters of HF.

Methods: We studied 82 consecutive chronic symptomatic HF patients with systolic LV dysfunction (ejection fraction <45%). The serum OS level was determined using thermochemiluminescence assay. We compared the serum OS levels with patients' clinical and prognostic parameters.

Results: Higher serum OS levels were associated with higher New York Heart Association class (P = .01), worse renal function (serum urea, creatinine, and creatinine clearance) (P<.001) and higher serum levels of hs-C-reactive protein and N-terminal pro brain natriuretic peptide (P = .001, P<.001, respectively).

Conclusions: In chronic systolic HF patients, high serum OS levels correlate with advanced disease and known markers of poor prognosis.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Valgimigli M, Merli E, Malagutti P, et al. Hydroxyl radical generation, levels of tumor necrosis factor‐alpha, and progression to heart failure after acute myocardial infarction. J Am Coll Cardiol. 2004; 43: 2000–2008. - PubMed
    1. Fragasso G, Palloshi A, Puccetti P, et al. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol. 2006; 48: 992–998. - PubMed
    1. Li Y, Takemura G, Okada H, et al. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc Res. 2006; 71: 684–694. - PubMed
    1. Pacher P, Schulz R, Liaudet L, Szabo C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci. 2005; 26: 302–310. - PMC - PubMed
    1. Jonsson G, Abdelnoor M, Seljeflot I, et al. The antioxidative effects of long‐term treatment are more pronounced for carvedilol than for atenolol in post‐myocardial infarction patients. J Cardiovasc Pharmacol. 2007; 49: 27–32. - PubMed

Publication types